Lenalidomide and thalidomide in the treatment of chronic pain

Author： Asher Christopher Furnish Timothy

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.12, Iss.3, 2013-05, pp. : 367-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High VTE rates with thalidomide, lenalidomide

Reactions Weekly, Vol. 1, Iss. 1133, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Antidepressants for the Treatment of Chronic Pain

By Verdu Bénédicte

Drugs, Vol. 68, Iss. 18, 2008-01 ,pp. : 2611-2632

Adis International

Access to resources Recommend Favorite

Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia

Current Cancer Drug Targets, Vol. 16, Iss. 8, 2016-10 ,pp. : 689-700

Bentham Science Publishers

Access to resources Recommend Favorite

Managing the teratogenic risk of thalidomide and lenalidomide: an industry perspective

By Bwire Robert Freeman John Houn Florence

Expert Opinion on Drug Safety, Vol. 10, Iss. 1, 2011-01 ,pp. : 3-8

Informa Healthcare

Access to resources Recommend Favorite

Pregabalin in the Treatment of Chronic Pain: An Overview

By Chiechio S.

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 203-213

Adis International

Access to resources Recommend Favorite